KANSL1, KAT8 regulatory NSL complex subunit 1, 284058

N. diseases: 140; N. variants: 332
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Chromosome 17q21.31 Deletion Syndrome
0.750 Biomarker disease BEFREE KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur. 29352316 2018
Chromosome 17q21.31 Deletion Syndrome
0.750 GeneticVariation disease BEFREE This case expands the mild end of the neurodevelopmental spectrum seen in children with de novo KANSL1 mutation and KdVS. 28211987 2017
Chromosome 17q21.31 Deletion Syndrome
0.750 GeneticVariation disease BEFREE This study was designed to describe the spectrum of epilepsy phenotypes in Koolen-de Vries syndrome (KdVS), a genetic syndrome involving dysmorphic features, intellectual disability, hypotonia, and congenital malformations, that occurs secondary to 17q21.31 microdeletions and heterozygous mutations in KANSL1. 28440867 2017
Chromosome 17q21.31 Deletion Syndrome
0.750 Biomarker disease BEFREE Our results demonstrate the implication of KANSL1 in the manifestation of KdVS phenotypes and extend substantially our knowledge about biological processes affected by these mutations. 28704368 2017
Chromosome 17q21.31 Deletion Syndrome
0.750 GeneticVariation disease CLINVAR Molecular diagnostic experience of whole-exome sequencing in adult patients. 26633545 2016
Chromosome 17q21.31 Deletion Syndrome
0.750 Biomarker disease BEFREE Comparison of the phenotype of both the microdeletion and SNV patients does not show differences of clinical importance, stressing that haploinsufficiency of KANSL1 is sufficient to cause the full KdVS phenotype. 26306646 2016
Chromosome 17q21.31 Deletion Syndrome
0.750 CausalMutation disease CLINVAR Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients. 26424144 2015
Chromosome 17q21.31 Deletion Syndrome
0.750 Biomarker disease GENOMICS_ENGLAND Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. 22544363 2012
Chromosome 17q21.31 Deletion Syndrome
0.750 CausalMutation disease CLINVAR Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. 22544367 2012
Chromosome 17q21.31 Deletion Syndrome
0.750 CausalMutation disease CLINVAR Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. 22544363 2012
Chromosome 17q21.31 Deletion Syndrome
0.750 ChromosomalRearrangement disease ORPHANET Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome. 19447831 2009
Chromosome 17q21.31 Deletion Syndrome
0.750 Biomarker disease CTD_human
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group BEFREE KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur. 29352316 2018
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 GeneticVariation group BEFREE 10-year-old female with intragenic KANSL1 mutation, no KANSL1-related intellectual disability, and preserved verbal intelligence. 28211987 2017
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group BEFREE KANSL1 gene expression studies and comparative clinical analysis of patients with 17q21.31 deletions and intragenic KANSL1 gene defects indicate that KANSL1 dysfunction is associated with the full spectrum of the 17q21.31 microdeletion syndrome, which includes characteristic facial features, hypotonia, intellectual disability, and structural defects of the brain, heart and genitourinary system, as well as, musculoskeletal and neuroectodermal anomalies. 26293599 2015
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 GeneticVariation group BEFREE The degree of intellectual disability (ID) appears to be milder than expected in a considerable number of subjects with either chromosome deletion or KANSL1 mutation. 26424144 2015
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group BEFREE We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features. 22544363 2012
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group CTD_human Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. 22544367 2012
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group CTD_human We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features. 22544363 2012
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.450 Biomarker group HPO
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.400 Biomarker phenotype CTD_human We show that haploinsufficiency of KANSL1 is sufficient to cause the 17q21.31 microdeletion syndrome, a multisystem disorder characterized by intellectual disability, hypotonia and distinctive facial features. 22544363 2012
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.400 Biomarker phenotype CTD_human Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. 22544367 2012
CUI: C0026827
Disease: Muscle hypotonia
Muscle hypotonia
0.400 CausalMutation phenotype CLINVAR
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.300 Biomarker disease CTD_human A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. 31043753 2019
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.300 Biomarker disease CTD_human A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. 31043753 2019